Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
GILD
GILD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest GILD ETF News Today | Earnings, Events & Price Alerts
GILD News
Gilead Foundation Invests $12 Million to Strengthen HIV Prevention Efforts
19h ago
Newsfilter
Significant Milestones in Biotech Sector This Week
3d ago
NASDAQ.COM
Novartis and Genentech Sue Over Drug Importation
4d ago
Newsfilter
Novartis and Genentech Sue Over Illegal Drug Import Scheme
4d ago
CNBC
Analysis of DFAC Stock's 52-Week High and Low Points
4d ago
NASDAQ.COM
Barron’s Top Fund Families for 2025
5d ago
Barron's
Gilead's BIC/LEN Pill Maintains Viral Suppression in HIV Trials
5d ago
seekingalpha
Gilead's New Drug Combination Shows Significant Efficacy in HIV Treatment
5d ago
Newsfilter
Gilead's New HIV Treatment Shows Promise in Phase 3 Trials
5d ago
Businesswire
Merck's New HIV Medication Shows Comparable Results to Gilead's Biktarvy in Phase 3 Trials as Keytruda Patent Expiration Approaches
5d ago
Barron's
2026 CNBC Changemakers List Highlights Women Transforming Business
5d ago
CNBC
Novo Nordisk Faces Market Pressures and Competition
5d ago
CNBC
Rolls-Royce CEO Aims to Become Largest Company on London Stock Exchange
6d ago
CNBC
Global Oncology Market Expected to Reach $748.17 Billion
6d ago
PRnewswire
Global Oncology Market Expected to Reach $748.17 Billion
6d ago
Newsfilter
Financial Stocks Plummet While ImmunityBio Soars
Feb 23 2026
CNBC
Show More News
